Home > Press > Xerox Fuels Innovation Engine with 584 New Patents in 2007
Abstract:
* The news: Xerox was awarded 584 patents in 2007, up 31 percent from 2005.
* The background: Company is delivering on promise to boost 2005 patent awards by one-third within three years.
* Why it matters: Inventions enable Xerox to quicken pace of digital document system and services development, resulted in 39 new products and services in 2007.
Xerox Corporation (NYSE: XRX) was granted 584* U.S. utility patents in 2007, adding to its extensive intellectual property portfolio. Many of the patents are already fueling new technologies embedded in products and services Xerox brought to market within the last year, while others provide the foundation for the next generation of products, services and software. The total includes patents awarded to the Palo Alto Research Center, a wholly owned subsidiary of Xerox Corporation.
Spanning specialties ranging from nanotechnology, controls and materials synthesis to software systems and smart document technologies for services, the patent total represents an increase of 31 percent over patents awarded to Xerox in 2005. At that time, Xerox announced a goal of boosting the number of patents it was awarded by one third in three years. With a year to go, the company is well on its way to delivering on that goal.
Xerox's joint venture partner in Japan, Fuji Xerox Co. Ltd., was awarded 317 U.S. utility patents, bringing the total for the Xerox Group to 901. Together, Xerox and Fuji Xerox invest about $1.5 billion annually in research and development.
"Inventions are not innovations until they delight our customers. Over the past years, Xerox has focused its extensive RD&E efforts to deliver breakthrough innovations, which have been embedded in products and services generating billions of dollars in recurring revenue for the company," said Sophie Vandebroek, Xerox chief technology officer and president of the Xerox Innovation Group. "Last year Xerox brought 39 new products and services to market. As importantly, our inventors have laid the groundwork for many more, some of which will expand our reach into new industries."
Among the patents granted in 2007 that may appear in future Xerox products and services:
* U.S. Patent No. 7,225,401, which describes a system and method for generating a custom document. This patent uses intelligent reasoning methods to help authors create documents by suggesting similar previous documents to use as a starting point.
* U.S. Patent No. 7,254,772, which describes systems and methods for visually representing the aging or expiration of electronic documents. It could help users manage documents by changing the appearance of screen icons to reflect the age or expiration date of the document.
* U.S. Patent No. 7,293,868, which describes a new ink composition that could be used in future solid ink products. Curable by ultraviolet light, it provides a five-fold improvement in image durability while maintaining excellent image quality and paper durability.
* U.S. Patent No. 7,184,032, which provides a simple method for accommodating blind users by use of a Braille overlay for control screens.
* U.S. Patent No. 7,163,269, which provides a simple and systematic method for achieving consistent color books in print-on-demand systems.
Patents granted in 2007 that are already delivering revenue include:
* U.S. Patent No. 7,295,346, which describes a new image processing method used in the iGen3™ Digital Production Press, the DocuColor™ 8000 press and other Xerox color printers. It has improved sharpness and image quality for gray or colored fonts and graphics. Last year more than 40 billion pages were made on Xerox color systems.
* U.S. Patent No. 7,157,200, which describes an emulsion aggregation toner and developer with superior image quality. The toner covered in this patent is used in the Nuvera™ EA Digital Production System and provides lower cost, improved reliability, better image quality, and better paper flatness.
####
About Xerox Corporation
Xerox Corporation is the world's leading document management, technology and services enterprise, providing the industry's broadest portfolio of color and black-and-white document processing systems and related supplies, as well as document management consulting and outsourcing services. This past year Xerox was awarded the National Medal of Technology, the highest technology award in the United States. For more information, visit http://www.xerox.com/innovation.
Note: *Patent totals are preliminary in anticipation of the official U.S. Patent and Trademark Office reports and represent utility patents issued to Xerox Corporation or its wholly owned subsidiaries during the 2007 calendar year.
For more information on Xerox, visit http://www.xerox.com or http://www.xerox.com/news . For open commentary and industry perspectives, visit http://www.xerox.com/blogs or http://www.xerox.com/podcasts .
Xerox®, the Xerox wordmark and the spherical connection symbol are trademarks of Xerox Corporation in the United States and/or other countries.
For more information, please click here
Contacts:
Xerox Corporation
Bill McKee, 585-423-4476 or 585-737-9069
or
Riedman Communications for Xerox
Laurie Riedman, 585-396-3100
Copyright © Business Wire 2008
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Patents/IP/Tech Transfer/Licensing
Getting drugs across the blood-brain barrier using nanoparticles March 3rd, 2023
Metasurfaces control polarized light at will: New research unlocks the hidden potential of metasurfaces August 13th, 2021
Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||